Stocks sink after vaccine maker expresses Omicron considerations
Traders are weighing the influence of the brand new COVID-19 variant, though economists say the outlook is unclear.
28M in the past
Source link
Stocks slip after Moderna CEO says vaccines may not work as well against Omicron
